CYP 2.13% 23.0¢ cynata therapeutics limited

Ann: Positive 6-Month Data from Cohort 1 in Phase 1 Trial in GvHD, page-36

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 35,472 Posts.
    lightbulb Created with Sketch. 2863
    Not sure we can read too much into todays very low vol. (dragonfly doji)

    BUT, you'd expect interest to build into the Cohort B result due by end June and end of any EOFY adjustments.

    Next WED is 28 days already. Big milestone...and as noted by a few here and MSB even, the 28 day is a very good indication of the 100 day...which Fuji will base option on.

    game changer once we have a first commercial deal signed.
    potentially and conservatively valued at a recurring A$40m pa at peak, if you look at MSBs recent broker report of a $1b market for GvHD (Japan/US) then Fuji are being conservative at US$300m market share imo.

    Given recent comparisons and results, I am confident we have a more effective product in the making.
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
23.0¢
Change
-0.005(2.13%)
Mkt cap ! $41.55M
Open High Low Value Volume
23.5¢ 23.5¢ 23.0¢ $18.19K 78.25K

Buyers (Bids)

No. Vol. Price($)
3 62836 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 15000 3
View Market Depth
Last trade - 13.38pm 04/11/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.